Tuberculosis (TB) is a leading cause of death worldwide from a single infectious agent, now ranking above HIV/AIDS, and only surpassed by COVID-19.

Explore what UCSF is doing to combat tuberculosis.

Immunology & Bench Science

Data Science

Epidemiology & Public Health

Therapeutics, Trials & Pharmacokinetics

Diagnostics & Biomarker Discovery

Implementation Science

Education & Assistance

Policy & Guidelines

Clinical Sciences

Mission: Improving the lives of TB patients worldwide through the training of the next generation of scientists and the acceleration of advances in tuberculosis research, practice, and policy.

Learn more about the Center for TB

Leadership

Babak Javid, MB, PhD

Associate Director, Bench Science, UCSF Center for Tuberculosis

Medicine

Dr. Javid is a physician-scientist, Wellcome Trust Investigator and Associate Professor in the Division of Experimental Medicine at UCSF. His research focuses on fundamental mycobacterial pathophysiology, regulation of adaptive protein synthesis, molecular mechanisms of antibiotic tolerance and human humoral immunity to tuberculosis. He went to medical school at the University of Cambridge, and after residency in general (internal) medicine returned to Cambridge to study for a PhD in immunobiology as an MRC training fellow. Following fellowship in infectious diseases, Dr.

Rada Savic, PhD

Associate Director, Data Science, UCSF Center for Tuberculosis

Bioengineering

With an emphasis on TB therapeutics, my research uses computational methods to study the dynamic interplay between disease progression, drug and biomarker response across relevant scales (molecule, cell, tissue, organ & whole body) in order to determine causal links underlying variability in (safety and efficacy) clinical outcomes.

Payam Nahid, MD, MPH

Director, UCSF Center for Tuberculosis

Medicine

Dr. Nahid is Professor of Medicine in the Division of Pulmonary and Critical Care Medicine. His research includes the conduct of clinical trials and translational research in TB with the goal of improving the care of patients with TB and HIV/TB worldwide. Dr. Nahid’s research focuses on clinical trials, epidemiological and translational TB research in international settings. He is leads a Vietnam National Tuberculosis Programme-partnered Clinical Trials Unit (CTU) in Hanoi, Vietnam.